Drreddys Laboratories | RDY - Capital De Empréstimo





Capital De Empréstimo Alterar Data
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Canopy Growth CAD 217.12M 7.87M 2026-03
Cipla INR 3.82B 840.2M 2026-03
Drreddys Laboratories INR 12.2B 12.07B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Novartis USD 37.49B 42M 2026-06
Pacira USD 363.12M 4.53M 2026-06
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 2.02B 1.01B 2026-06
Richter Gedeon HUF 15.07B 75M 2026-03
Sun Pharmaceuticals INR 3.93B 309.9M 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06